Brind.

JNJ-1900 has been licensed by Janssen Pharmaceutica NV.

1 report, 0 independent Updated Jul 8

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Johnson & Johnson Nano

Keep exploring

The entities involved

Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
- P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04
Nano
Nothing else this week.

Related events

Johnson & Johnson developed JNJ-5120/PIPE-307 under a global license.Sep 14
JNJ secured marketing authorization from the U.S. FDA, and its Ottava platform challenges ISRG's market dominance.Jul 24
Johnson & Johnson highlighted growth opportunities within the MedTech sector.Sep 10
Nanobiotix and Johnson & Johnson are collaborating on nanotherapeutics. Laurent Levy is the CEO of Nanobiotix.Thu 22:13
Johnson & Johnson is reportedly considering a sale of its orthopedics business unit within DePuy Synthes.Sep 15

Coverage

Newest first; wire copies grouped

Jul 8Unknown outlet